Literature DB >> 15371773

Endoscopic treatment with dextranomer/hyaluronic acid for complex cases of vesicoureteral reflux.

Marcos Perez-Brayfield1, Andrew J Kirsch, Terry W Hensle, Martin A Koyle, Peter Furness, Hal C Scherz.   

Abstract

PURPOSE: The surgical correction of primary vesicoureteral reflux (VUR) is highly successful. This success decreases in more complex cases and often involves reoperation and increased morbidity. We present our experience with the use of subureteral injection of dextranomer/hyaluronic acid (Dx/HA) in complex cases of vesicoureteral reflux in which open surgery would have been indicated.
MATERIALS AND METHODS: Between October 2001 and July 2003, 72 patients 9 months to 31 years old (mean age 5.6 years) underwent subureteral injection of Dx/HA for complex VUR at our institutions. Dx/HA was injected submucosally within the intramural ureter (modified STING) in most cases. A guidewire was used to manipulate the ureteral orifice and a retrograde ureterogram was used to delineate the anatomy in selected cases. The average volume of injected material was measured for each ureter. Renal sonography was performed to determine if hydronephrosis was present. At 3 months fluoroscopic voiding cystourethrograms were used to evaluate for the presence of VUR.
RESULTS: A total of 93 ureters were treated in 55 girls and 17 boys. All cases were considered to be complex as 17 had persistent reflux after open surgery (7 megaureters repairs, 2 extravesical repairs, 7 intravesical reimplants and 1 blind ureter), 11 had persistent reflux and neurogenic bladder, 7 had ectopic ureters to bladder neck, 6 had bilateral Hutch diverticulum, 6 had persistent stump reflux, 5 had ureterocele after puncture or incision, 15 had duplications, 1 had the prune belly syndrome, 2 had posterior urethral valve following resection, 1 had epispadias and 1 had urogenital sinus. The average maximum reflux grade was IV. An average of 1.1 cc (range 0.4 to 2) was injected per ureter. Of the patients 69 had 3-month followup results. The overall success rate was 68% after 1 implantation (47 of 69).
CONCLUSIONS: Submucosal intraureteral implantation with Dx/HA corrected complex vesicoureteral reflux in 68% of patients. In all of these patients open surgery would have potentially been difficult. The use of fluoroscopy and/or guidewires is a useful adjunct in these cases. We believe that this minimally invasive approach is warranted as an initial step in the management of complex cases of VUR before resorting to more difficult open surgical procedures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371773     DOI: 10.1097/01.ju.0000139013.00908.1c

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

Review 1.  Vesicoureteral reflux: From prophylaxis to surgery.

Authors:  Anne-Sophie Blais; Stéphane Bolduc; Katherine Moore
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

2.  [Vesicorenal reflux in childhood].

Authors:  G Zöller; C Radmayr; C Schwentner; C Persson de Geeter; R Stein; R H Ringert
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

3.  Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment.

Authors:  Göran Läckgren; Arne Stenberg
Journal:  Ther Adv Urol       Date:  2009-08

4.  The treatment of vesicoureteral reflux in children by endoscopic sub-mucosal intra-ureteral injection of dextranomer/hyaluronic acid: A case-series, multi-centre study.

Authors:  Osama Bawazir
Journal:  Electron Physician       Date:  2017-04-25

5.  Endoscopic correction of complex cases of vesicoureteral reflux utilizing Vantris as a new non-biodegradable tissue-augmenting substance.

Authors:  Boris Chertin; Wael Abu Arafeh; Stanislav Kocherov
Journal:  Pediatr Surg Int       Date:  2014-04       Impact factor: 1.827

6.  Endoscopic treatment of vesicoureteral reflux in children with posterior urethral valves.

Authors:  Tayfun Oktar; Omer Acar; Ahmet Sancaktutar; Oner Sanlı; Tzevat Tefik; Orhan Ziylan
Journal:  Int Urol Nephrol       Date:  2012-07-06       Impact factor: 2.370

Review 7.  Management of duplex system ureteroceles in neonates and infants.

Authors:  Marco Castagnetti; Alaa El-Ghoneimi
Journal:  Nat Rev Urol       Date:  2009-06       Impact factor: 14.432

8.  Diagnosis and management of congenital bladder diverticulum in infancy and childhood: experience with nine cases at a tertiary health center in a developing country.

Authors:  Jiledar Rawat; Kumar Abdul Rashid; Ravi P Kanojia; Shiv N Kureel; Raj K Tandon
Journal:  Int Urol Nephrol       Date:  2008-08-15       Impact factor: 2.370

9.  Pediatric enterocystoplasty: long-term complications and controversies.

Authors:  Eric A Kurzrock
Journal:  World J Urol       Date:  2008-10-10       Impact factor: 4.226

Review 10.  Does deflux alter the paradigm for the management of children with vesicoureteral reflux?

Authors:  Ian A Aaronson
Journal:  Curr Urol Rep       Date:  2005-03       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.